SIX4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.791000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.739600E-01
Normal-vs-Stage2
2.606600E-01
Normal-vs-Stage3
3.633000E-01
Normal-vs-Stage4
3.393800E-01
Stage1-vs-Stage2
2.217800E-01
Stage1-vs-Stage3
6.622200E-01
Stage1-vs-Stage4
5.359800E-01
Stage2-vs-Stage3
4.081900E-02
Stage2-vs-Stage4
5.293400E-01
Stage3-vs-Stage4
7.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.833400E-01
Normal-vs-AfricanAmerican
4.230800E-01
Normal-vs-Asian
3.452800E-01
Caucasian-vs-AfricanAmerican
3.745600E-01
Caucasian-vs-Asian
9.531200E-01
AfricanAmerican-vs-Asian
4.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.261600E-01
Normal-vs-Female
3.306400E-01
Male-vs-Female
8.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.060600E-01
Normal-vs-Age(41-60Yrs)
2.125800E-01
Normal-vs-Age(61-80Yrs)
2.991800E-01
Normal-vs-Age(81-100Yrs)
4.378400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.345600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.180200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.575200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.681800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.676100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.697200E-01
Normal-vs-Daily Drinker
3.261200E-01
Normal-vs-Weekly Drinker
1.517630E-01
Normal-vs-Occasional Drinker
1.346980E-01
Normal-vs-Social Drinker
3.106400E-01
Non Drinker-vs-Daily Drinker
6.373800E-01
Non Drinker-vs-Weekly Drinker
9.743000E-01
Non Drinker-vs-Occasional Drinker
3.545700E-02
Non Drinker-vs-Social Drinker
4.669600E-01
Daily Drinker-vs-Weekly Drinker
5.769800E-01
Daily Drinker-vs-Occasional Drinker
1.622270E-02
Daily Drinker-vs-Social Drinker
3.110800E-01
Weekly Drinker-vs-Occasional Drinker
3.320200E-02
Weekly Drinker-vs-Social Drinker
5.022800E-01
Occasional Drinker-vs-Social Drinker
1.961210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.581800E-01
Normal-vs-Grade 2
7.384200E-01
Normal-vs-Grade 3
4.952400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.478000E-01
Grade 1-vs-Grade 3
2.100600E-01
Grade 1-vs-Grade 4
8.581800E-01
Grade 2-vs-Grade 3
9.586300E-02
Grade 2-vs-Grade 4
7.384200E-01
Grade 3-vs-Grade 4
4.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.466600E-01
Normal-vs-NonDiabetic
2.703800E-01
Diabetic-vs-NonDiabetic
9.165500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.457000E-01
Normal-vs-NoPancreatitis
2.793000E-01
Pancreatitis-vs-NoPancreatitis
6.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.162200E-01
Normal-vs-N1
2.737600E-01
N0-vs-N1
8.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.282000E-02
Normal-vs-TP53-NonMutant
4.728800E-01
TP53-Mutant-vs-TP53-NonMutant
2.757600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
